US 8071618
Caspase inhibitors and uses thereof
granted A61PA61P1/04A61P1/16
Quick answer
US patent 8071618 (Caspase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P1/04, A61P1/16, A61P1/18, A61P11/00